Page last updated: 2024-08-24

capecitabine and Nasopharyngeal Carcinoma

capecitabine has been researched along with Nasopharyngeal Carcinoma in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (19.05)	24.3611
2020's	17 (80.95)	2.80

Authors

Authors	Studies
Gao, Y; Liu, Y; Liu, Z	1
Chen, QY; Guo, SS; Liu, LT; Mai, HQ; Sun, XS; Tang, LQ; Zhu, MY	1
Chua, MLK; Lee, AWM; Ng, WT	1
Bei, WX; Cai, ZC; Chen, X; Guo, X; Ke, LR; Li, WZ; Liang, CX; Liang, H; Liu, GY; Lu, N; Lv, SH; Lv, X; Wang, DS; Xia, WX; Xiang, YQ; Ye, YF; Zhao, C	1
Ayyoub, S; Sultan, I	1
Killock, D	1
Cao, KJ; Chen, MY; Chen, QY; Chen, ZJ; Guo, L; Guo, X; Hu, D; Hua, YJ; Huang, PY; Ke, LR; Li, WZ; Liang, H; Liu, GY; Liu, T; Lu, N; Luo, DH; Lv, SH; Lv, X; Mai, HQ; Mo, HY; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Tang, WB; Tong, LH; Wang, DS; Wang, L; Xia, WX; Xiang, YQ; Yang, W; Ye, YF; Yuan, TZ; Zhang, HX; Zhao, C	1
Li, WZ; Liu, GY; Xiang, YQ	1
Ganguly, S; Gogia, A	1
Pramanik, R; S G, N; Sharma, A	1
Bossi, P; Chan, AT; Even, C; Machiels, JP	1
Chen, N; Han, J; He, J; Lan, X; Shen, X; Tian, K	1
Cai, XY; Chen, QY; Chen, ZB; Fang, WF; Hu, PL; Hu, WH; Li, XY; Li, YJ; Li, ZM; Lin, MZ; Liu, ZG; Mai, HQ; Peng, JY; Tang, LQ; Wang, XC; Xia, LP; Yang, YP; Yu, QW; Zhang, B; Zhao, C; Zhou, H; Zhou, J	1
Chen, QY; Li, XY; Liang, YJ; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ	1
Chan, ATC; Chappell, R; Cheng, AAC; Choi, HCW; Kwong, DLW; Lee, AWM; Lu, TX; Ng, WT; Ngan, RKC; Sze, HCK; Tung, SY; Wong, FCS; Yiu, HHY; Yuen, KT	1
Chan, SK; Chan, SY; Choi, HC; Kwong, DL; Lam, KO; Lee, AW; Lee, VH; Leung, TW; Luk, MY; Tong, CC	1
Chen, L; Chen, YP; Feng, HX; Guo, R; Guo, Y; Hu, GQ; Hu, WH; Huang, J; Jin, F; Li, L; Li, WF; Lin, Q; Liu, X; Liu, ZZ; Luo, XL; Lv, JW; Ma, J; Mao, YP; Mei, Q; Shen, LF; Shi, M; Shi, YX; Sun, R; Sun, Y; Tang, LL; Tian, Y; Wang, H; Wang, XC; Wu, H; Wu, HF; Wu, SG; Xie, FY; Xu, C; Xu, J; Yang, KY; Yue, D; Zang, J; Zhang, N; Zhang, Y; Zheng, BM; Zhou, GQ; Zhou, Q; Zhu, XD	1
Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Wang, XX	1
Chan, AT; Chan, LL; Chan, OS; Chappell, R; Cheng, A; Cheung, FY; Choi, H; Kwong, DL; Lee, AW; Lu, TX; Ng, WT; Ngan, RK; Tung, SY; Wong, F; Yau, S; Yiu, H; Yuen, KT	1
Kwong, D; Lam, KO; Lee, V; Leung, TW	1
Jiang, X; Wang, YX; Yan, D; Yan, S; Yang, J	1

Trials

7 trial(s) available for capecitabine and Nasopharyngeal Carcinoma

Article	Year
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Rand JAMA oncology, 2022, 04-01, Volume: 8, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Progression-Free Survival	2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA oncology, 2022, 05-01, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel	2022
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial. BMC medicine, 2023, 03-16, Volume: 21, Issue:1 Topics: Capecitabine; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prospective Studies	2023
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma. Cancer, 2020, 08-15, Volume: 126, Issue:16 Topics: Adolescent; Adult; Aged; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Recurrence, Local; Neoplasm Staging; Progression-Free Survival; Treatment Outcome; Young Adult	2020
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet (London, England), 2021, 07-24, Volume: 398, Issue:10297 Topics: Administration, Metronomic; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Young Adult	2021
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fr Cancer, 2015, Apr-15, Volume: 121, Issue:8 Topics: Adult; Aged; Capecitabine; Carcinoma; Chemoradiotherapy, Adjuvant; Deoxycytidine; Dose Fractionation, Radiation; Fluorouracil; Humans; Induction Chemotherapy; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Young Adult	2015

Other Studies

14 other study(ies) available for capecitabine and Nasopharyngeal Carcinoma

Article	Year
Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects. World journal of surgical oncology, 2021, Sep-17, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Quality of Life	2021
Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine? Oral oncology, 2021, Volume: 122 Topics: Capecitabine; Chemoradiotherapy; Humans; Maintenance Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies	2021
Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box? JAMA oncology, 2022, 04-01, Volume: 8, Issue:4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2022
Long-term survival in a patient with recurrent nasopharyngeal carcinoma treated with capecitabine. Pediatric blood & cancer, 2022, Volume: 69, Issue:7 Topics: Capecitabine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local	2022
Maintenance capecitabine is beneficial in NPC. Nature reviews. Clinical oncology, 2022, Volume: 19, Issue:4 Topics: Capecitabine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Progression-Free Survival	2022
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma-Reply. JAMA oncology, 2022, 08-01, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2022
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma. JAMA oncology, 2022, 08-01, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2022
Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma. JAMA oncology, 2022, 08-01, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2022
ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2023, Volume: 34, Issue:3 Topics: Capecitabine; Combined Modality Therapy; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2023
Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma. Frontiers in public health, 2022, Volume: 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms	2022
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study. Cancer communications (London, England), 2020, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Propensity Score; Retrospective Studies; Survival Rate; Young Adult	2020
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinom Oral oncology, 2021, Volume: 114 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Progression-Free Survival; Prospective Studies; Treatment Outcome; Young Adult	2021
Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report. Journal of medical case reports, 2016, Sep-07, Volume: 10, Issue:1 Topics: Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Female; Humans; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiodermatitis	2016
Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Carcinoma, Hepatocellular; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated	2012